API prices have been under pressure over the past few quarters due to weak demand and competition from China in export ...

Autolus’ Aucatzyl is a B-lymphocyte antigen CD19 CAR-T cell therapy. Credit: NDAB Creativity via Shutterstock. Autolus ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good afternoon, everyone, and welcome to the Atea Pharmaceuticals Third Quarter 2024 Financial Results and Business Update Conference Call.

GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

Drug shortages in the U.S. are increasing in number and duration, primarily affecting generic and multi-sourced drugs that ...

Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update. Clarity Pharmaceuticals has strengthened its production capabilities by signing ...

The pharmaceutical industry is poised for an opportunity to tweak parts of the Medicare drug pricing negotiation law, after ...

We are bullish on Avid's potential take-private deal by Ampersand and GHO, predicting value creation and optimistic about ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...